High Risk Groups
People at Especially High Risk
As resistance grows, the antibiotics used to treat infections do not work as well or at all. The loss of effective antibiotic treatments will not only cripple the ability to fight routine infectious disease but will also undermine treatment of infectious complications in patients with other disease. Many of the advances in medical treatment – joint replacements, organ transplants, cancer therapy, and treatment of chronic diseases such as diabetes, asthma, rheumatoid arthritis – are dependent on the ability to fight infections with antibiotics. If that ability is lost, the ability to safely offer people many life-saving and life-improving modern medical advantages will be lost with it. For example:
![cancer chemotherapy image](https://www.cdc.gov/drugresistance/images/4-cancer-chemotherapy.png)
For specific information on preventing infections in patients receiving chemotherapy, visit CDC’s Preventing Infections in Cancer Patients
![complex surgery image](https://www.cdc.gov/drugresistance/images/4-complex-surgery.png)
![rheumatoid arthritis image](https://www.cdc.gov/drugresistance/images/4-rheumatoid-arthritis.png)
![dialysis for end-stage renal disease image](https://www.cdc.gov/drugresistance/images/4-dialysis.png)
![organ and bone marrow transplants image](https://www.cdc.gov/drugresistance/images/4-organ-transplant.png)
No hay comentarios:
Publicar un comentario